Keyphrases
Human Cell Lines
100%
Nucleoside Analogues
100%
Tick-borne Encephalitis
100%
Differential Activity
100%
Yellow Fever
100%
Antiviral Activity
80%
Tick-borne Encephalitis Virus
80%
Virus
40%
Sofosbuvir
40%
Uprifosbuvir
40%
Remdesivir
40%
Antiretroviral Therapy
20%
Ribavirin
20%
Head-to-head Comparison
20%
Reducing Activity
20%
Liver Cells
20%
Neuronal Cells
20%
Potent Drugs
20%
Re-emergence
20%
Nucleos(t)ide Analogues
20%
Galidesivir
20%
Molnupiravir
20%
Experimental Assays
20%
Medicine and Dentistry
Cell Line
100%
Tick Borne Encephalitis
100%
Yellow Fever Virus
100%
Tick Borne Encephalitis Virus
80%
Antiviral Activity
80%
Sofosbuvir
40%
Remdesivir
40%
Uprifosbuvir
40%
Ribavirin
20%
Antiviral Therapy
20%
Clinical Study
20%
Liver Cell
20%
Nervous System Cell
20%
Galidesivir
20%
Valopicitabine
20%
Immunology and Microbiology
Cell Line
100%
Human Cell
100%
Yellow Fever Virus
100%
Tick-Borne Encephalitis
100%
Antiviral Activity
80%
Tick Borne Encephalitis Virus
80%
Sofosbuvir
40%
Ribavirin
20%
Liver Cell
20%